Home › Funds › Atle Fund Management AB › RVMD

Atle Fund Management AB position in RVMD

REVOLUTION MEDICINES INC · Health Care

Atle Fund Management AB reported holding 66,113 shares of RVMD (REVOLUTION MEDICINES INC) in its Q3 2026 13F filing — a position valued at US$13.6M, representing 3.63% of its reported portfolio and ranking #8 among its reported holdings. Atle Fund Management AB has disclosed RVMD holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)66.11K sh
Reported value held$13.57M
Portfolio Weight3.63%
First reportedQ4 2024
Last changeReduce
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Atle Fund Management AB's RVMD position evolved

Atle Fund Management AB first disclosed a stake in RVMD in Q4 2024 at 62,161 shares (US$2.7M). The position peaked in Q2 2026 at 73,077 shares, worth US$13.7M. Across 8 filings, Atle Fund Management AB increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 66,113 shares valued at US$13.6M — a reduction of -6,964 shares quarter over quarter.. Notable position changes include a 50% increase in Q2 2025 (shares rose 27% over the following quarter), a 584% increase in Q1 2026 (shares rose 93% over the following quarter), a 88% trim in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 62.16K $2.68M New
Q1 2025 54.96K $1.94M Reduce
Q2 2025 82.28K $3.03M Add
Q3 2025 85.36K $423.18K Add
Q4 2025 90.18K $7.18M Add
Q1 2026 617.25K $9.08M Add
Q2 2026 73.08K $13.69M Reduce
Q3 2026 66.11K $13.57M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RVMD and 13F data

RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 61 other funds we track also report a position in RVMD — the largest reported positions include Farallon Capital Management (US$2.54B), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RVMD

All RVMD fund holders →

FAQ

How long has Atle Fund Management AB held RVMD?

Atle Fund Management AB has disclosed RVMD holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Atle Fund Management AB's current position in RVMD?

As of Q3 2026, Atle Fund Management AB holds 66.11K shares of RVMD (REVOLUTION MEDICINES INC), valued at $13.57M, representing 3.63% of its reported portfolio and ranking #8.

Has Atle Fund Management AB been buying or selling RVMD?

In the latest 13F filing (Q3 2026), Atle Fund Management AB reduced its position in RVMD. The position peaked in Q2 2026 at 73.08K shares.

Which other funds hold RVMD?

Other major institutional holders of RVMD include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., BAKER BROS. ADVISORS LP, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.